Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for burn-induced acute renal failure
IRCT20100418003742N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acute kidney failure (AKF) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: Change in urea level and Change in creatinine level. Started Nov 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20100418003742N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100418003742N5.